Turner Syndrome
📧 Sign up to get email alerts when something new happens for Turner Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector
A completed clinical trial evaluated the convenience and adherence of the Easypod electronic self-injector for growth hormone therapy in con…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Initiating Transdermal Estradiol Therapy in Turner's Syndrome [Phase 1]
A Phase 1 trial evaluating transdermal estradiol for Turner syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Long Term Follow up Study of Predictive Markers in GHD and TS Children
A long-term follow-up study evaluating predictive biomarkers in children with growth hormone deficiency and Turner syndrome. The trial has c…
-
CLINICAL_TRIALS research · 2014-02-10Clinical Trial Update: Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism [Phase 4]
Phase 4 clinical trial updating estrogen dosing, pharmacology, and metabolism in Turner syndrome with hypogonadism.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study [Phase 4]
Phase IV open-label pharmacogenetics study validating genetic markers linked to growth response in pre-pubertal children with growth hormone…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Comparison of Aneuploidy Risk Evaluations
This clinical trial update reports on a completed study comparing methods for evaluating fetal aneuploidy risk in pregnancy, including Down …
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Non-invasive Prenatal Diagnostic Validation Study
The study completed validation of a non-invasive prenatal diagnostic test for fetal chromosomal abnormalities.
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome [Phase 4]
A Phase 4 clinical trial in Turner Syndrome examining the optimal hormonal replacement therapy has completed.
-
FDA approval · 2013-04-19FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA supplemental approval for Genotropin (somatropin) from Pfizer, authorizing an approved supplemental application to modify or expand its …
-
FDA approval · 2013-04-04FDA Approved: OMNITROPE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Omnitrope (somatropin) from Sandoz Inc, potentially expanding or updating the product’s labe…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
A completed clinical trial evaluated bone mineral density in adolescents with growth hormone deficiency due to pituitary dwarfism or Turner …
-
CLINICAL_TRIALS research · 2012-11-14Clinical Trial Update: A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
Completed clinical trial evaluating growth hormone treatment for Turner Syndrome, sponsored by Genentech.
-
CLINICAL_TRIALS research · 2012-08-20Clinical Trial Update: Turner Syndrome Prenatal Diagnosis Study
This clinical trial update concerns a prenatal diagnosis study for Turner syndrome sponsored by Seattle Children's Hospital, with the curren…
-
EMA withdrawal · 2012-08-14EMA Withdrawn: Valtropin (somatropin) — BioPartners GmbH
Valtropin (somatropin) by BioPartners GmbH has been withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents [Phase 4]
Phase 4 trial evaluating the Norditropin NordiFlex device versus the device previously used by patients or their parents; the study is compl…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome [Phase 3]
A Phase 3 clinical trial evaluating androgen and growth hormone effects on height and learning in girls with Turner syndrome has completed.
-
CLINICAL_TRIALS research · 2011-11-08Clinical Trial Update: Growth Hormone Treatment of Women With Turner Syndrome [NA]
The clinical trial evaluating growth hormone treatment in women with Turner syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Beta Cell Function in Women With Turner Syndrome
This clinical trial update reports on a study evaluating beta cell function in women with Turner syndrome. The trial has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG [Phase 3]
This update summarizes the completion of a Phase III open-label study evaluating the local tolerability of ZOMACTON 10MG in Turner syndrome.
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome [Phase 3]
Phase 3 clinical trial of somatropin in patients with SHOX deficiency and Turner syndrome has completed. Sponsored by Eli Lilly and Company.
-
FDA approval · 2010-07-28FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company, authorizing changes to the existing p…
-
FDA approval · 2010-04-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals Inc. The action represents an additional regu…
-
FDA approval · 2010-02-02FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Genotropin (somatropin) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Somatropin Treatment to Final Height in Turner Syndrome [Phase 3]
Phase 3 trial evaluating somatropin to achieve final height in Turner syndrome has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
A completed clinical trial update discusses a non-invasive maternal plasma marker for screening fetal aneuploidies, including trisomies 21, …